Tony Gordon, Genesis Genomics Managing Director (US) and Lab Director (UK) discusses how the Illumina portfolio empowers reproductive health labs with its ability to run both pre-and postnatal tests on the same Illumina equipment. Learn more about how next-generation sequencing (NGS) is advancing reproductive genetic health. http://www.illumina.com/clinical/reproductive-genetic-health.html?sciid=2014243IBN1